Discover why IBB's focused approach makes it preferable to XBI. Learn about their objectives, diversification, and ...

Issues ranging from medicine approval delays to attacks on Harvard research grants knock driver of regional economy ...

HQH offers high yields with a biotech and small/mid-cap tilt, but relies on capital payouts, making it less tax efficient and ...

The NATO Innovation Fund has made its first investment in a biotechnology company, it said on Monday, seeking to enhance ...

Nann Luneborg and co-founder Sander Slootweg sit down with Bloomberg Intelligence analyst Sam Fazeli to explain Forbion’s ...

KKR & Co.-backed venture capital firm Catalio Capital Management gathered more than $400 million for its latest fund, a ...

Could synthetic macrocyclic peptides be the Next Big Thing to lift biotech? A potential $1.5 billion deal suggests things are ...

Legend Biotech Corporation (NASDAQ:LEGN) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...

The expert jury selected Dragan Grabulovski, Ph.D., Philipp Spycher, Ph.D., and Isabella Attinger-Toller, Ph.D. of Araris ...